ABOUT US
Mosaic Therapeutics is an oncology therapeutics company delivering precision medicines for patient groups with few targeted treatment options today. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery - leveraging our differentiated dual technology platform to advance novel combination therapies.
Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety of oncology indications and disease biology pathways.
Company Details
- Employees
- 26
- Founded
- -
- Address
- Building 960, Babraham Research Campus,united Kingdom
- Industry
- Biotechnology
- Website
- http://www.mosaic-tx.com
- Keywords
- oncology, therapeutics, tumour agnostic therapies, genomics, organoids, Targeted combination therapy, drug discovery, drug development, precision medicine, machine learning.
- HQ
- Babraham, Cambridgeshire
Mosaic Tx Questions
Mosaic Tx's website is http://www.mosaic-tx.com
Mosaic Tx's LinkedIn profile is https://uk.linkedin.com/company/mosaic-tx
Mosaic Tx has
26 employees.
View email and phone details for 26
employees at Mosaic Tx.
Mosaic Tx's industry is
Biotechnology
Mosaic Tx's top competitors are
Wellcome Sanger Institute,
Insmed Incorporated,
Xap Therapeutics,
4basebio,
Syncona Limited,
Astex Pharmaceuticals,
Neobe Therapeutics,
Storm Therapeutics Limited,
Bicycle Therapeutics,
Maxion Therapeutics.
Mosaic Tx's categories are Biotechnology
Mosaic Tx's founding year is 2020
